GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2526 - 2550** of **4050** in total

« First

‹ Prev

…

98

99

100

101

102

103

104

105

106

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 1	6	moderate	G30839DN	30
IgM	Patient 1	10	moderate	G30839DN	54
IgM	Patient 1	22	moderate	G30839DN	206
IgA	Patient 2	15	mild	G30839DN	431
IgA	Patient 2	24	mild	G30839DN	474
IgG	Patient 2	15	mild	G30839DN	410
IgG	Patient 2	24	mild	G30839DN	381
IgM	Patient 2	15	mild	G30839DN	340
IgM	Patient 2	24	mild	G30839DN	340
IgM	Patient 1	6	moderate	G30839DN	54
IgA	Patient 2	3	mild	G30839DN	483
IgG	Patient 2	3	mild	G30839DN	628
IgM	Patient 2	3	mild	G30839DN	444
IgA	Patient 3	-180	mild	G30839DN	269
IgA	Patient 3	11	mild	G30839DN	453
IgG	Patient 3	-180	mild	G30839DN	60
IgM	Patient 3	-180	mild	G30839DN	83
IgA	Patient 3	4	mild	G30839DN	489
IgG	Patient 3	11	mild	G30839DN	238
IgG	Patient 3	4	mild	G30839DN	225
IgM	Patient 3	11	mild	G30839DN	164
IgM	Patient 3	4	mild	G30839DN	166
IgA	Patient 4	12	mild	G30839DN	463
IgG	Patient 4	12	mild	G30839DN	552
IgM	Patient 4	12	mild	G30839DN	168